ArticleHarm reduction journal2018
Assessing pharmacy student experience with, knowledge of and attitudes towards harm reduction: illuminating barriers to pharmacist-led harm reduction.
Article in Harm reduction journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 40 citations in OpenAlex.
- Perspectives on harm reduction kit implementation in heterogeneous outpatient clinics.Substance abuse treatment, prevention, and policy · 2026Article
- Perspectives on Harm Reduction Kit Implementation in Heterogeneous Outpatient Clinics.Research square · 2026Article
- Associations Between Healthcare Providers' Stigmatizing Attitudes Toward People Living with HIV and People Who Use Drugs: A Canonical Correlation Analysis.AIDS and behavior · 2025Article
- Sterile syringe availability in Georgia pharmacies remained rare, despite policy change permitting sales.Harm reduction journal · 2025Article
- High-dose naloxone formulations are not as essential as we thought.Harm reduction journal · 2024Review
- Professional stigma towards clients with methamphetamine use disorder - a qualitative study.Journal of pharmaceutical policy and practice · 2024Article
- Article
- Assessing Student Readiness to Work with People Who Use Drugs: Development of a Multi-disciplinary Addiction Educational Survey.Journal of general internal medicine · 2022Review
- Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022Article
- A longitudinal study of naloxone opioid overdose awareness and reversal training for first-year medical students: specific elements require reinforcement.Harm reduction journal · 2022Article
- Healthcare Professional Students' Perspectives on Substance Use Disorders and Stigma: A Qualitative Study.International journal of environmental research and public health · 2022Article
- Perspectives of Stakeholders of Equitable Access to Community Naloxone Programs: A Literature Review.Cureus · 2022Review
- The Role of Misinformation and Stigma in Opioid Use Disorder Treatment Uptake.Substance use & misuse · 2022Article
- "Innovations in pharmacy · 2021Article
- Report of the 2020 Special Committee on Substance Use and Pharmacy Education.American journal of pharmaceutical education · 2020Article
- Attitudes of HIV healthcare Provider Attitudes Towards PWH who use Drugs and acceptance of harm reduction strategies: a cross-sectional study.Therapeutic advances in infectious diseaseArticle
- Readiness of community pharmacies to implement an opioid safety intervention.Journal of the American Pharmacists Association : JAPhAArticle
- Identifying Provider Barriers to the Implementation of Opioid Harm Reduction Methods: An Initial Narrative Review.Inquiry : a journal of medical care organization, provision and financingReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAs the burden from the opioid epidemic continues to increase in the state of Minnesota and across the nation, the University of Minnesota College of Pharmacy seeks to design an innovative, comprehensive harm reduction curriculum in order to better train student pharmacists to serve the varied needs of the greater community. This study examines incoming individuals' baseline knowledge of and attitudes toward harm reduction in order to better inform curriculum planning and to ultimately produce pharmacists capable of impacting the devastating effects of the opioid crisis.
methodsIncoming first-year pharmacy students took a survey focused on their knowledge of opioid overdose and the drug naloxone and also provided written reflections on their perceptions of harm reduction. Data was coded using consensual qualitative research (CQR) into appropriate domains.
resultsPharmacy students beginning their professional education revealed a lack of knowledge of proper response to an overdose situation, with 18.56% unfamiliar with the opioid antagonist drug naloxone. Close to 10% (9.58%) of students expressed unwillingness to do anything other than call an ambulance during an overdose event, while 8.98% were either unsure or felt that they would not feel compelled to do something to help. Qualitative coding revealed many barriers to students' becoming capable harm reductionists, including lack of knowledge of substance use, addiction, and harm reduction, in addition to the presence of bias and stigma.
conclusionIn order to interrupt the cycle of misinformation and stigma within the larger community and the subgroup of medical providers, gaps in student knowledge must be addressed in meaningful, specific ways over the course of their pharmacy education. Evaluating baseline knowledge and beliefs informs the design of a flexible, action-oriented curriculum to produce well-trained pharmacists ready to engage in finding solutions to the opioid crisis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.